Freestone Capital Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-387
Closed -$77.4K 1051
2020
Q4
$77.4K Buy
387
+114
+42% +$23.2K ﹤0.01% 476
2020
Q3
$59.9K Buy
+273
New +$57.8K ﹤0.01% 461

Other funds holding TDOC

Freestone Capital Holdings's TDOC Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 387 shares — an estimated $77.4K sold.

Freestone Capital Holdings first reported a position in TDOC in Q3 2020 and held it in 2 quarters. The position peaked at $77.4K in Q4 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 387 Teladoc Health shares in Q1 2021, an estimated $77.4K.
  • Freestone Capital Holdings first reported a position in Teladoc Health in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Teladoc Health position peaked at $77.4K in Q4 2020.
  • 889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.